文献速递慢阻肺

什么是慢阻肺急性加重?当前定义、缺陷、挑战与改进机会

What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement.
PubMed 文献 · Eur Respir J · 2018-11-15

慢阻肺急性加重以呼吸困难、咳嗽、咳痰加重为特征,临床与经济后果严重。现行定义不完善,主要症状非特异,可源于其他心肺疾病。文章提出一个可能更特异的定义,纳入呼吸困难视觉模拟评分≥5分及氧饱和度、血中性粒细胞或嗜酸性粒细胞、C反应蛋白等实验室标准,并需排除肺炎、肺水肿及其他病因。

要点

  • 现行慢阻肺急性加重定义不完善,主要症状非特异,需排除其他心肺疾病。
  • 文章提出更特异的定义:呼吸困难视觉模拟评分≥5分,伴或不伴咳嗽咳痰加重。
  • 实验室标准包括氧饱和度较稳定状态下降≤4%、血中性粒细胞≥9000·mm⁻³或血嗜酸性粒细胞≥2%、C反应蛋白≥3 mg·L⁻¹,并排除肺炎、肺水肿及其他病因。

核心结论

  • 当前慢阻肺急性加重定义不完善,存在诸多问题,文章提出一个可能更特异的定义供改进参考。

研究设计与样本

  • 本文为综述,讨论慢阻肺急性加重定义的现状、缺陷、挑战与改进机会。

主要发现

  • 慢阻肺急性加重常见,可导致工作生产力丧失、医疗资源利用增加、肺功能与运动能力暂时或永久下降、住院甚至死亡。
  • 慢阻肺急性加重的主要症状非特异,也可由慢阻肺以外的急性心肺疾病引起。

关键数值与推荐

  • 提议定义:呼吸困难急性或亚急性加重,视觉模拟评分(0-10分)≥5分,有时伴咳嗽、痰量或痰脓性增加,但不一定。
  • 必要实验室标准:氧饱和度较稳定状态下降≤4%,血中性粒细胞≥9000·mm⁻³或血嗜酸性粒细胞≥2%,C反应蛋白≥3 mg·L⁻¹。
  • 需胸部影像学无肺炎或肺水肿证据,且其他病因实验室检查阴性。

临床怎么用

  • 临床诊断慢阻肺急性加重时应排除其他心肺疾病,避免仅凭非特异症状诊断。
  • 可参考提议定义中的症状评分与实验室指标提高诊断特异性,但需结合临床判断。

局限性

  • 现行定义不完善,提议定义可能更特异但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic obstructive pulmonary disease (COPD) is a chronic illness that can be periodically punctuated by exacerbations, characterised by acute worsening of symptoms, including increased dyspnoea, cough, sputum production and sputum purulence. COPD exacerbations are common and have important clinical and economic consequences, including lost work productivity, increased utilisation of healthcare resources, temporary or permanent reductions in lung function and exercise capacity, hospitalisation, and sometimes death. Over the past two decades, clinicians and researchers have broadened their treatment goals for COPD to extend beyond improving lung function and symptoms, and have begun to address the importance of preventing and reducing exacerbations. However, despite the best efforts of clinicians and guideline committees, current definitions of COPD exacerbations are imperfect and fraught with problems. The cardinal symptoms of a COPD exacerbation are nonspecific and can result from acute cardiorespiratory illnesses other than COPD. A proposed definition, which may be more specific than current definitions, suggests that COPD exacerbation be defined as an acute or subacute worsening of dyspnoea (≥5 on a visual analogue scale that ranges from 0 to 10) sometimes but not necessarily accompanied by increased cough, sputum volume and/or sputum purulence. Necessary laboratory criteria for an exacerbation include oxygen desaturation ≤4% below that of stable state, elevated levels of circulating blood neutrophils or eosinophils (≥9000 neutrophils·mm-3 or ≥2% blood eosinophils) and elevated C-reactive protein (≥3 mg·L-1), without evidence of pneumonia or pulmonary oedema on chest radiography and with negative laboratory test results for other aetiologies. Herein, we discuss the current state of the art with respect to how we define COPD exacerbations, associated pitfalls and challenges, and opportunities for improvement.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J. 2018. PMID: 30237306. doi:10.1183/13993003.01261-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。